KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $1.8 billion.

  • Thermo Fisher Scientific's Free Cash Flow fell 311.51% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 billion, marking a year-over-year decrease of 2140.19%. This contributed to the annual value of $7.3 billion for FY2024, which is 490.83% up from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Free Cash Flow is $1.8 billion, which was down 311.51% from $1.1 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's 5-year Free Cash Flow high stood at $3.3 billion for Q4 2023, and its period low was $271.0 million during Q2 2023.
  • Its 5-year average for Free Cash Flow is $1.6 billion, with a median of $1.6 billion in 2021.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Free Cash Flow skyrocketed by 121067.96% in 2021, and later plummeted by 8265.04% in 2023.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Free Cash Flow stood at $1.6 billion in 2021, then surged by 80.63% to $2.9 billion in 2022, then increased by 12.97% to $3.3 billion in 2023, then decreased by 15.31% to $2.8 billion in 2024, then tumbled by 34.7% to $1.8 billion in 2025.
  • Its Free Cash Flow stands at $1.8 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $361.0 million for Q1 2025.